Literature DB >> 9817389

Stem cell features of benign and malignant prostate epithelial cells.

A M De Marzo1, W G Nelson, A K Meeker, D S Coffey.   

Abstract

PURPOSE: We present a new hypothesis suggesting that the different malignant potential of benign prostatic hyperplasia (BPH) and high grade prostatic intraepithelial neoplasia may be explained by distinct alterations in stem cell-like properties.
MATERIALS AND METHODS: We used our results and the recent literature to develop this hypothesis in the context of an updated prostate stem cell model.
RESULTS: While high grade prostatic intraepithelial neoplasia is a likely precursor lesion to many prostatic adenocarcinomas, BPH rarely if ever progresses directly to carcinoma. Prostate epithelium contains basal and secretory compartments. Secretory cells appear to differentiate from basal cells. Thus, prostatic stem cells most likely reside in the basal compartment. In BPH there is a slight increase in epithelial proliferation, yet most replicating epithelial cells within BPH maintain their normal restriction to the basal compartment. In high grade prostatic intraepithelial neoplasia there is a marked increase in cell proliferation. In contrast to BPH, the majority of proliferating cells in high grade prostatic intraepithelial neoplasia reside in the secretory compartment. The biological significance of this topographic infidelity of proliferation in high grade prostatic intraepithelial neoplasia remains unclear but may relate mechanistically to down regulation of the cyclin dependent kinase inhibitor, p27kip1. Normal basal cells express GSTP1, an enzyme that inactivates reactive electrophiles and organic hydroperoxides, and that may protect cells from deoxyribonucleic acid damaging agents. In contrast, normal secretory cells and high grade prostatic intraepithelial neoplasia cells do not express this enzyme.
CONCLUSIONS: We propose that topographic infidelity of proliferation produces a population of secretory cells replicating in the absence of key genome protective mechanisms, thus setting the stage for an accumulation of genomic alterations and instability in high grade prostatic intraepithelial neoplasia. This action occurs along with activation of telomerase, resulting in an immortal clone capable of developing into invasive carcinoma. The model predicts that genome protection remains intact in BPH, minimizing its malignant potential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817389     DOI: 10.1097/00005392-199812020-00004

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  49 in total

1.  Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.

Authors:  Sabina Davidsson; Michelangelo Fiorentino; Ove Andrén; Fang Fang; Lorelei A Mucci; Eberhard Varenhorst; Katja Fall; Jennifer R Rider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-27       Impact factor: 4.254

2.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.

Authors:  Patricia E Burger; Xiaozhong Xiong; Sandra Coetzee; Sarah N Salm; David Moscatelli; Ken Goto; E Lynette Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-17       Impact factor: 11.205

4.  Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.

Authors:  Shunyou Wang; Alejandro J Garcia; Michelle Wu; Devon A Lawson; Owen N Witte; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

Authors:  I Leav; K M Lau; J Y Adams; J E McNeal; M E Taplin; J Wang; H Singh; S M Ho
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

6.  Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.

Authors:  S M Goodyear; M D Amatangelo; M E Stearns
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

Review 7.  Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

Review 8.  Exploring the origins of the normal prostate and prostate cancer stem cell.

Authors:  Susan Kasper
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

9.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Van Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; William B Isaacs; Jun Luo; Angelo M De Marzo
Journal:  Mod Pathol       Date:  2008-06-20       Impact factor: 7.842

10.  Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  FASEB J       Date:  2009-11-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.